COPD is a complex multi-component disease characterized by chronic systemic inflammation that frequently coexists with multiple comorbidities. Comorbidities in COPD are common at any stage of the disease, are important determinants of outcomes, and contribute to significant economic consequences. Despite this, disease management strategies fail to provide clear recommendations on how comorbidities should be identified, assessed, and managed in the presence of COPD. In 2017 we identified gaps in the literature pertaining to COPD co-morbidities. This session will address these gaps based on updated evidence.
CME credits and/or Certificates of Completion are not provided for this session.
1- Develop an understanding of selected, prevalent comorbidities associated with COPD
2- Develop knowledge of new care approaches and health care delivery related to the presence of multiple comorbidities
Nina Elise Bracken, MSN, ACNPC: Welcome and Introduction
Paula M. Meek, PhD, ATSF, RN, BC: The Management of Both COPD and Dyspnea
Janet L. Larson, PhD, RN: Targeting Obesity in COPD
Susan S. Jacobs, RN, MS: Hypoxia and the Trials and Tribulations of Using Supplemental Oxygen in COPD
Eileen G. Collins, PhD, ATSF: Consequences and Clinical Manifestations of De-Conditioning in COPD
Lea Ann Matura, PhD, RN: Summary and Discussion
You can save 20% today by joining the ATS. Join more than 16,000 healthcare providers and researchers as a member of the American Thoracic Society today. As an ATS member, you’ll gain access to cutting-edge science, collaboration opportunities, discounts on the annual ATS International Conference, and resources to share with patients. The ATS offers multiple ways to get involved, from Assembly membership to in-person networking opportunities, as well as an online community offered through DocMatter. Join the ATS Today!